Free Trial

Neuronetics (STIM) News Today

→ Don’t make this retirement mistake (From Sasco Gold LLC) (Ad)
Free STIM Stock Alerts
$2.03
+0.01 (+0.50%)
(As of 02:53 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 9 at 5:54 AM | americanbankingnews.com
Insider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Purchases $102,500.00 in Stock
June 7, 2024 | insidertrades.com
Robert Cascella Purchases 50,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) Stock
June 6, 2024 | marketbeat.com
Insider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Purchases 50,000 Shares of Stock
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) Director Robert Cascella acquired 50,000 shares of the firm's stock in a transaction that occurred on Thursday, June 6th. The stock was acquired at an average cost of $2.05 per share, with a total value of $102,500.00. Following the completion of the acquisition, the director now directly owns 244,098 shares in the company, valued at $500,400.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
May 28, 2024 | marketbeat.com
Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Decrease in Short Interest
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 18,000 shares, a decline of 69.1% from the April 30th total of 58,300 shares. Based on an average trading volume of 176,600 shares, the short-interest ratio is currently 0.1 days.
May 27, 2024 | marketbeat.com
Millrace Asset Group Inc. Has $2.10 Million Holdings in Neuronetics, Inc. (NASDAQ:STIM)
Millrace Asset Group Inc. boosted its stake in Neuronetics, Inc. (NASDAQ:STIM - Free Report) by 205.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 725,369 shares of the company's stock after purchasing an a
May 24, 2024 | msn.com
Neuronetics to Present at William Blair Growth Conference
May 23, 2024 | globenewswire.com
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
May 15, 2024 | msn.com
William Blair Upgrades Neuronetics (STIM)
May 15, 2024 | globenewswire.com
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 14, 2024 | marketbeat.com
Neuronetics (NASDAQ:STIM) Upgraded to "Outperform" at William Blair
William Blair raised shares of Neuronetics from a "market perform" rating to an "outperform" rating in a research note on Tuesday.
May 10, 2024 | msn.com
Neuronetics Boasts 12% Revenue Increase, Expands Depression Treatment Sector
May 10, 2024 | marketbeat.com
Q2 2024 EPS Estimates for Neuronetics, Inc. Cut by William Blair (NASDAQ:STIM)
Neuronetics, Inc. (NASDAQ:STIM - Free Report) - William Blair dropped their Q2 2024 earnings estimates for Neuronetics in a research note issued to investors on Tuesday, May 7th. William Blair analyst M. Kaczor now anticipates that the company will post earnings of ($0.27) per share for the quart
May 9, 2024 | finance.yahoo.com
Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 9, 2024 | seekingalpha.com
Neuronetics: Reality Set In
May 8, 2024 | markets.businessinsider.com
Strong Buy Rating for Neuronetics Backed by Solid Financials and Growth Prospects
May 8, 2024 | finance.yahoo.com
Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript
May 8, 2024 | markets.businessinsider.com
Buy Rating on Neuronetics: Solid Fundamentals and Growth Despite Challenges
May 8, 2024 | finance.yahoo.com
Neuronetics Inc (STIM) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth Amidst ...
May 8, 2024 | wsj.com
Neuronetics Inc.
May 7, 2024 | msn.com
Neuronetics GAAP EPS of -$0.27 beats by $0.04, revenue of $17.42M beats by $0.3M
May 7, 2024 | msn.com
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024
May 7, 2024 | finance.yahoo.com
Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses
May 7, 2024 | globenewswire.com
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
May 6, 2024 | msn.com
Neuronetics Q1 2024 Earnings Preview
May 4, 2024 | finance.yahoo.com
Neuronetics, Inc. (STIM)
May 4, 2024 | msn.com
Neuronetics Awards Stock Options to New Employees as Inducement
May 3, 2024 | globenewswire.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2024 | globenewswire.com
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
April 27, 2024 | marketbeat.com
Neuronetics, Inc. (NASDAQ:STIM) Sees Large Drop in Short Interest
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) saw a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 57,700 shares, a decrease of 39.0% from the March 31st total of 94,600 shares. Based on an average trading volume of 170,500 shares, the short-interest ratio is presently 0.3 days.
April 25, 2024 | msn.com
Neuronetics Announces Q1 2024 Earnings Release and Conference Call
April 23, 2024 | globenewswire.com
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
April 12, 2024 | marketbeat.com
Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Rises By 77.8%
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 94,600 shares, a growth of 77.8% from the March 15th total of 53,200 shares. Based on an average trading volume of 199,100 shares, the days-to-cover ratio is currently 0.5 days.
April 12, 2024 | msn.com
New Study Offers Hope for Depression Patients Undergoing TMS Therapy
April 10, 2024 | globenewswire.com
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
April 6, 2024 | marketbeat.com
Kent Lake Capital LLC Has $3.24 Million Stake in Neuronetics, Inc. (NASDAQ:STIM)
Kent Lake Capital LLC decreased its stake in shares of Neuronetics, Inc. (NASDAQ:STIM - Free Report) by 52.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,116,041 shares of the company's stock after selling 1,213,246 shares during the
April 5, 2024 | benzinga.com
Neuronetics Stock (NASDAQ:STIM), Quotes and News Summary
April 1, 2024 | msn.com
Neuronetics Bolsters Talent Pool with Strategic Stock Incentives for New Hires
March 29, 2024 | msn.com
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder
March 28, 2024 | marketbeat.com
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update
Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 53,200 shares, a decrease of 64.9% from the February 29th total of 151,700 shares. Based on an average daily volume of 204,300 shares, the short-interest ratio is presently 0.3 days.
March 27, 2024 | finance.yahoo.com
Neuronetics wins FDA clearance for device to treat adolescents with depression
March 27, 2024 | finance.yahoo.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2024 | globenewswire.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2024 | markets.businessinsider.com
Buy Rating for Neuronetics Amid FDA Clearance and Expanding Adolescent MDD Market
March 26, 2024 | marketbeat.com
Neuronetics' (STIM) "Market Perform" Rating Reiterated at William Blair
William Blair reiterated a "market perform" rating on shares of Neuronetics in a report on Tuesday.
March 25, 2024 | msn.com
Neuronetics’s NeuroStar wins FDA clearance for adolescents with depression
March 25, 2024 | finanznachrichten.de
Neuronetics: NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
March 25, 2024 | marketwatch.com
Neuronetics Shares Climb 15% After FDA Cleared Depression Treatment for Adolescents Aged 15 to 21
March 25, 2024 | markets.businessinsider.com
Neuronetics: NeuroStar Advanced Therapy Gets FDA Clearance For New Indication
March 25, 2024 | globenewswire.com
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
March 16, 2024 | finance.yahoo.com
STIM Apr 2024 5.000 put
Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.

Don’t make this retirement mistake (Ad)

If you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.

Reserve your seat here.

STIM Media Mentions By Week

STIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

STIM
News Sentiment
▼
1.43

0.74
▲
Average
Medical
News Sentiment

STIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

STIM Articles
This Week
▼
4

2
▲
STIM Articles
Average Week

Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:STIM) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Executive Order To Wipe Out Your Bank Accounts
Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...
Oasis Gold | Sponsored
Must-See: Elon’s New Invention is Absolutely Insane
Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...
InvestorPlace | Sponsored
Nvidia’s Quiet $1 Trillion Pivot
Nvidia recently added $277 billion in market cap … IN ONE DAY.
Weiss Ratings | Sponsored
NVDA to close the AI “wealth window’ June 25?
On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...
Paradigm Direct | Sponsored
The Greatest LEGAL Transfer of Wealth in History is Underway
What's the #1 Stock to Build Generational Wealth RIGHT NOW? One Wall Street millionaire will give you a sur...
Stansberry Research | Sponsored
DON’T buy gold until you read this
If you're an American who understands that your money is rotting away as you read this email… Then this is ...
Sasco Gold LLC | Sponsored
Gold Set to EXPLODE!
The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...
Gold Safe Exchange | Sponsored